PubMed

Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal?

Brown SM.

Ann Intern Med. 2007 Dec 18;147(12):882; author reply 882-3. No abstract available. PMID: 18087061 [PubMed - indexed for MEDLINE]Related articlesFree article

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.PMID: 17310045 [PubMed - indexed for MEDLINE]Related articlesFree article

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.PMID: 17314337 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.

Bateman ED, van Dyk M, Sagriotis A.

Pulm Pharmacol Ther. 2008;21(1):20-5. Epub 2006 Oct 13.PMID: 17118684 [PubMed - indexed for MEDLINE]Related articles

Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?

Gillissen A.

Am J Respir Crit Care Med. 2008 Jul 1;178(1):105; author reply 106-7. No abstract available. PMID: 18565963 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Hodder R, Kesten S, Menjoge S, Viel K.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67.PMID: 18044688 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.

Tashkin DP.

Am J Med. 2006 Oct;119(10 Suppl 1):63-72. Review.PMID: 16996901 [PubMed - indexed for MEDLINE]Related articles

Combined salmeterol and fluticasone for COPD.

Vassiliou V.

Lancet. 2003 May 10;361(9369):1651; author reply 1652-3. No abstract available. PMID: 12747901 [PubMed - indexed for MEDLINE]Related articles

Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.

Keating GM, McCormack PL.

Drugs. 2007;67(16):2383-405. Review.PMID: 17983257 [PubMed - indexed for MEDLINE]Related articles

Tiotropium in chronic obstructive pulmonary disease.

Pedone C, Incalzi RA.

N Engl J Med. 2009 Jan 8;360(2):185; author reply 187. No abstract available. PMID: 19129533 [PubMed - indexed for MEDLINE]Related articles

COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):257-8. No abstract available. PMID: 18092426 [PubMed - indexed for MEDLINE]Related articles

[Inhaled corticosteroids in patients with COPD: maintain current guidelines]

Heijdra YF.

Ned Tijdschr Geneeskd. 2007 Oct 6;151(40):2195-7. Dutch. PMID: 17969568 [PubMed - indexed for MEDLINE]Related articles

Fluticasone/salmeterol: labeling change.

[No authors listed]

Prescrire Int. 2008 Dec;17(98):229.PMID: 19418648 [PubMed - indexed for MEDLINE]Related articles

Prevention of death in COPD.

Barnes PJ.

N Engl J Med. 2007 May 24;356(21):2211; author reply 2213-4. No abstract available. PMID: 17522406 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.

[No authors listed]

Ann Intern Med. 2007 Apr 17;146(8):I12. Epub 2007 Feb 19. No abstract available. PMID: 17310044 [PubMed - indexed for MEDLINE]Related articlesFree article

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.

Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group.

Respir Med. 2004 Nov;98(11):1045-50.PMID: 15526804 [PubMed - indexed for MEDLINE]Related articles

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.

Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK; SCO30005 Study Group.

Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43. Epub 2006 Jan 19.PMID: 16424444 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Kardos P, Wencker M, Glaab T, Vogelmeier C.

Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9. Epub 2006 Oct 19.PMID: 17053207 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined salmeterol and fluticasone for COPD.

Khamis RY, Rajakulasingam RK.

Lancet. 2003 May 10;361(9369):1652; author reply 1652-3. No abstract available. PMID: 12747905 [PubMed - indexed for MEDLINE]Related articles

Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.

Dransfield MT, Bailey WC.

Expert Opin Pharmacother. 2004 Aug;5(8):1815-26. Review.PMID: 15264996 [PubMed - indexed for MEDLINE]Related articles